نبذة مختصرة : Female reproductive system disorders (FRSD) with or without infertility are prevalent women's health problems with a variety of treatment approaches including surgery and hormone therapy. It currently considering to sub-branch of regenerative medicine including stem cells or growth factors injection-based delivery treatment might be improved female reproductive health life. The most common products used for these patients treatment are autologous cell or platelet-based products from patients, including platelet-rich plasma, plasma rich in growth factor, platelet-rich fibrin, and stromal vascular fraction. In this review, we discuss each of the above products used in treatment of FRSD and critically evaluate the clinical outcome. © 2020
Relation: Valizadeh, A. and Asghari, S. and Bastani, S. and Sarvari, R. and Keyhanvar, N. and Razin, S.J. and Khiabani, A.Y. and Yousefi, B. and Yousefi, M. and Shoae-Hassani, A. and Mahmoodpoor, A. and Hamishehkar, H. and Tavakol, S. and Keshel, S.H. and Nouri, M. and Seifalian, A.M. and Keyhanvar, P. (2021) Will stem cells from fat and growth factors from blood bring new hope to female patients with reproductive disorders? Reproductive Biology, 21 (2).
Processing Request
No Comments.